|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2004-4-15
|
|
pubmed:abstractText |
Nonselective inverse agonists at the gamma-aminobutyric acid(A) (GABA-A) benzodiazepine binding site have cognition-enhancing effects in animals but are anxiogenic and can precipitate convulsions. Herein, we describe novel GABA-A alpha5 subtype inverse agonists leading to the identification of 16 as an orally active, functionally selective compound that enhances cognition in animals without anxiogenic or convulsant effects. Compounds of this type may be useful in the symptomatic treatment of memory impairment associated with Alzheimer's disease and related dementias.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-2623
|
|
pubmed:author |
pubmed-author:AtackJohn RJR,
pubmed-author:CarlingRobert WRW,
pubmed-author:CastroJosé LJL,
pubmed-author:CollinsonNeilN,
pubmed-author:CookSusanS,
pubmed-author:DawsonGerard RGR,
pubmed-author:JelleyRichard ARA,
pubmed-author:LadduwahettyTamaraT,
pubmed-author:MacLeodAngus MAM,
pubmed-author:MerchantKevin JKJ,
pubmed-author:MooreKevin WKW,
pubmed-author:O'ConnorDesmondD,
pubmed-author:ReeveAustin JAJ,
pubmed-author:SeabrookGuyG,
pubmed-author:SohalBindiB,
pubmed-author:SternfeldFrancineF,
pubmed-author:StreetLeslie JLJ,
pubmed-author:TattersallF DavidFD,
pubmed-author:WaffordKeithK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
22
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2176-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15084116-Animals,
pubmed-meshheading:15084116-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:15084116-Binding, Competitive,
pubmed-meshheading:15084116-Biological Availability,
pubmed-meshheading:15084116-Convulsants,
pubmed-meshheading:15084116-Dogs,
pubmed-meshheading:15084116-GABA-A Receptor Agonists,
pubmed-meshheading:15084116-Humans,
pubmed-meshheading:15084116-Macaca mulatta,
pubmed-meshheading:15084116-Mice,
pubmed-meshheading:15084116-Nootropic Agents,
pubmed-meshheading:15084116-Oocytes,
pubmed-meshheading:15084116-Patch-Clamp Techniques,
pubmed-meshheading:15084116-Phthalazines,
pubmed-meshheading:15084116-Radioligand Assay,
pubmed-meshheading:15084116-Rats,
pubmed-meshheading:15084116-Receptors, GABA-A,
pubmed-meshheading:15084116-Structure-Activity Relationship,
pubmed-meshheading:15084116-Triazoles,
pubmed-meshheading:15084116-Xenopus laevis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers.
|
|
pubmed:affiliation |
The Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Terlings Park, Eastwick Road, Harlow, Essex, CM20 2QR, UK. francine_sternfeld@merck.com
|
|
pubmed:publicationType |
Journal Article
|
